This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bohm, M. Articles by Erdmann, E. Search for Related Content PubMed PubMed Citation Articles by Bohm, M. Articles by Erdmann, E.

Hypertension, Vol 22, 715-727, Copyright © 1993 by American Heart Association

ARTICLES

Cardiac adenylyl cyclase, beta-adrenergic receptors, and G proteins in salt-sensitive hypertension

M Bohm, P Gierschik, A Knorr, U Schmidt, K Weismann and E Erdmann
Medizinische Klinik I, Universitat Munchen, Klinikum Grosshadern, Germany.

The present study investigated whether high salt intake (8%) in Dahl salt-sensitive and salt-resistant rats with and without hypertension produces a heterologous desensitization of cardiac adenylyl cyclase as observed in various types of hypertension and human heart failure. In membranes from Dahl salt-sensitive rats on a high-salt diet (8%) basal, isoproterenol-, 5'-guanylylimidodiphosphate-, and forskolin-stimulated adenylyl cyclase was reduced compared with the low-salt (0.4%) group and Dahl salt-resistant rats on either 0.4% or 8% sodium chloride. The activity of the catalyst was depressed, and the expression of the immunodetectable inhibitory G proteins Gi alpha was increased in Dahl salt-sensitive rats on 8% sodium chloride, whereas the density of beta- adrenergic receptors and the activity of the stimulatory G protein Gs alpha reconstituted into Gs alpha-deficient S49 cyc- mouse lymphoma cell membranes were unchanged in any condition studied. We conclude that high salt intake in salt-sensitive hypertensive Dahl rats produces hypertension, cardiac hypertrophy, and heterologous desensitization of cardiac adenylyl cyclase. The latter alteration is due to an increase of Gi alpha proteins and a depressed catalyst activity of adenylyl cyclase. The results demonstrate that heterologous adenylyl cyclase desensitization can precede the development of contractile dysfunction in later stages and can occur independently of changes in beta- adrenergic receptors.

This article has been cited by other articles:

				A. El-Armouche, O. Zolk, T. Rau, and T. Eschenhagen Inhibitory G-proteins and their role in desensitization of the adenylyl cyclase pathway in heart failure Cardiovasc Res, December 1, 2003; 60(3): 478 - 487. [Abstract] [Full Text] [PDF]

				D. T. McCurdy, B. M. Palmer, D. W. Maughan, and M. M. LeWinter Myocardial cross-bridge kinetics in transition to failure in Dahl salt-sensitive rats Am J Physiol Heart Circ Physiol, September 1, 2001; 281(3): H1390 - H1396. [Abstract] [Full Text] [PDF]

				G. Iaccarino, E. Barbato, E. Cipolleta, A. Esposito, A. Fiorillo, W. J. Koch, and B. Trimarco Cardiac {beta}ARK1 Upregulation Induced by Chronic Salt Deprivation in Rats Hypertension, August 1, 2001; 38(2): 255 - 260. [Abstract] [Full Text] [PDF]

				R. Dash, V. J. Kadambi, A. G. Schmidt, N. M. Tepe, D. Biniakiewicz, M. J. Gerst, A. M. Canning, W. T. Abraham, B. D. Hoit, S. B. Liggett, et al. Interactions Between Phospholamban and {{beta}}-Adrenergic Drive May Lead to Cardiomyopathy and Early Mortality Circulation, February 13, 2001; 103(6): 889 - 896. [Abstract] [Full Text] [PDF]

				K. Nagata, C. Communal, C. C. Lim, M. Jain, T. M. Suter, F. R. Eberli, N. Satoh, W. S. Colucci, C. S. Apstein, and R. Liao Altered beta -adrenergic signal transduction in nonfailing hypertrophied myocytes from Dahl salt-sensitive rats Am J Physiol Heart Circ Physiol, November 1, 2000; 279(5): H2502 - H2508. [Abstract] [Full Text] [PDF]

				K. Strehlow, G. Nickenig, J. Roeling, S. Wassmann, O. Zolk, A. Knorr, and M. Bohm AT1 receptor regulation in salt-sensitive hypertension Am J Physiol Heart Circ Physiol, November 1, 1999; 277(5): H1701 - H1707. [Abstract] [Full Text] [PDF]

				N. Dzimiri Regulation of beta -Adrenoceptor Signaling in Cardiac Function and Disease Pharmacol. Rev., September 1, 1999; 51(3): 465 - 502. [Abstract] [Full Text] [PDF]

				O. Zolk, M. Flesch, G. Nickenig, P. Schnabel, and M. Bohm Alteration of intracellular Ca2+-handling and receptor regulation in hypertensive cardiac hypertrophy: insights from Ren2-transgenic rats Cardiovasc Res, July 1, 1998; 39(1): 242 - 256. [Abstract] [Full Text] [PDF]

				J. S. Mills, H. M. Miettinen, D. Barnidge, M. J. Vlases, S. Wimer-Mackin, E. A. Dratz, J. Sunner, and A. J. Jesaitis Identification of a Ligand Binding Site in the Human Neutrophil Formyl Peptide Receptor Using a Site-specific Fluorescent Photoaffinity Label and Mass Spectrometry J. Biol. Chem., April 24, 1998; 273(17): 10428 - 10435. [Abstract] [Full Text] [PDF]

				M. Bohm, O. Zolk, M. Flesch, F. Schiffer, P. Schnabel, J.-P. Stasch, and A. Knorr Effects of Angiotensin II Type 1 Receptor Blockade and Angiotensin-Converting Enzyme Inhibition on Cardiac ß-Adrenergic Signal Transduction Hypertension, March 1, 1998; 31(3): 747 - 754. [Abstract] [Full Text] [PDF]

				M. Bohm, M. Castellano, E. Agabiti-Rosei, M. Flesch, M. Paul, and E. Erdmann Dose-Dependent Dissociation of ACE-Inhibitor Effects on Blood Pressure, Cardiac Hypertrophy, and ß-Adrenergic Signal Transduction Circulation, November 15, 1995; 92(10): 3006 - 3013. [Abstract] [Full Text]

				M. Bohm, C. Grabel, A. Knorr, and E. Erdmann Treatment in Hypertensive Cardiac Hypertrophy, I : Neuropeptide Y and ß-Adrenoceptors Hypertension, May 1, 1995; 25(5): 954 - 961. [Abstract] [Full Text]

				M. Bohm, C. Grabel, M. Flesch, A. Knorr, and E. Erdmann Treatment in Hypertensive Cardiac Hypertrophy, II : Postreceptor Events Hypertension, May 1, 1995; 25(5): 962 - 970. [Abstract] [Full Text]